BC
Boxer Capital Portfolio holdings
AUM
$2.04B
This Quarter Return
+3%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
–
AUM
$237M
AUM Growth
+$237M
(+17%)
Cap. Flow
+$33.9M
Cap. Flow
% of AUM
14.3%
Top 10 Holdings %
Top 10 Hldgs %
88.05%
Holding
33
New
6
Increased
3
Reduced
4
Closed
6
Top Buys
| 1 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$34.8M |
| 2 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$10.8M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
$9.36M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$9.18M |
| 5 |
MDCO
Medicines Co
MDCO
|
$4.35M |
Top Sells
| 1 |
BioMarin Pharmaceuticals
BMRN
|
$9.25M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$7M |
| 3 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$6.66M |
| 4 |
Rigel Pharmaceuticals
RIGL
|
$4.96M |
| 5 |
Heron Therapeutics
HRTX
|
$3.45M |
Sector Composition
| 1 | Healthcare | 87.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVET
26
DELISTED
Nexvet Biopharma plc Ordinary Shares
NVET
| $578K | 0.22% |
154,840
| – | – |
|
|
ONTXW
27
DELISTED
Onconova Therapeutics, Inc. Warrants
ONTXW
| $150K | 0.06% |
241,644
| – | – |
|
|
28
Rigel Pharmaceuticals
RIGL
$710M
| – | – |
-1,351,137
| Closed | -$4.96M |
|
|
29
Heron Therapeutics
HRTX
$204M
| – | – |
-200,000
| Closed | -$3.45M |
|
30
ESSA Pharma
EPIX
$11.2M
| – | – |
-28,100
| Closed | -$74K |
|
31
Carisma Therapeutics
CARM
$15.5M
| – | – |
-750,000
| Closed | -$2.1M |
|
|
32
BioMarin Pharmaceuticals
BMRN
$11.3B
| – | – |
-100,000
| Closed | -$9.25M |
|